Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (61-70 of 310) with videos related to

Pageof 31
Sort By:
BMC Infectious Diseases|January 30, 2008
Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot studyDelia Goletti, Stefania Carrara, Harriet Mayanja-Kizza, et al.
The European Respiratory Journal|March 25, 2022
Commemorating World Tuberculosis Day 2022: recent <i>ERJ</i> articles of critical relevance to ending TB and saving livesGiovanni Battista Migliori, Dennis Falzon, Guy B Marks, et al.
BMC Infectious Diseases|January 11, 2019
Severe chest allodynia as an unusual first presentation of hydatid disease: a case reportFlaminia Coluzzi, Roberto Luca Meniconi, Damiano Caruso, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responsesDelia Goletti, Linda Petrone, Davide Manissero, et al.
Tuberculosis (Edinburgh, Scotland)|April 8, 2026
Mycobacterial growth control is heterogeneous but maintained during treatment in patients with tuberculosis diseaseKrista E van Meijgaarden, Delia Goletti, Fabrizio Palmieri, et al.
Cytokine|March 12, 2002
Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonistDelia Goletti, Audrey L Kinter, Eliana M Coccia, et al.
Clinical and Diagnostic Laboratory Immunology|November 9, 2005
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assayDelia Goletti, Donatella Vincenti, Stefania Carrara, et al.
Cancer Immunology Research|January 25, 2022
Immune-Guided Therapy of COVID-19Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, et al.
Clinical and Vaccine Immunology : CVI|November 23, 2007
Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infectionsRaffaella Palazzo, Fabiana Spensieri, Marco Massari, et al.
International Journal of Rheumatology|August 13, 2014
HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-AnalysisFabrizio Cantini, Stefania Boccia, Delia Goletti, et al.
Pageof 31

Showing results (61-70 of 310) with videos related to

Sort By:
Pageof 31
BMC Infectious Diseases|January 30, 2008
Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot studyDelia Goletti, Stefania Carrara, Harriet Mayanja-Kizza, et al.
The European Respiratory Journal|March 25, 2022
Commemorating World Tuberculosis Day 2022: recent <i>ERJ</i> articles of critical relevance to ending TB and saving livesGiovanni Battista Migliori, Dennis Falzon, Guy B Marks, et al.
BMC Infectious Diseases|January 11, 2019
Severe chest allodynia as an unusual first presentation of hydatid disease: a case reportFlaminia Coluzzi, Roberto Luca Meniconi, Damiano Caruso, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responsesDelia Goletti, Linda Petrone, Davide Manissero, et al.
Tuberculosis (Edinburgh, Scotland)|April 8, 2026
Mycobacterial growth control is heterogeneous but maintained during treatment in patients with tuberculosis diseaseKrista E van Meijgaarden, Delia Goletti, Fabrizio Palmieri, et al.
Cytokine|March 12, 2002
Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonistDelia Goletti, Audrey L Kinter, Eliana M Coccia, et al.
Clinical and Diagnostic Laboratory Immunology|November 9, 2005
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assayDelia Goletti, Donatella Vincenti, Stefania Carrara, et al.
Cancer Immunology Research|January 25, 2022
Immune-Guided Therapy of COVID-19Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, et al.
Clinical and Vaccine Immunology : CVI|November 23, 2007
Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infectionsRaffaella Palazzo, Fabiana Spensieri, Marco Massari, et al.
International Journal of Rheumatology|August 13, 2014
HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-AnalysisFabrizio Cantini, Stefania Boccia, Delia Goletti, et al.
Pageof 31